TEM, SEM, and STEM-based immuno-CLEM workflows offer complementary advantages.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 01 2021
Historique:
received: 26 04 2020
accepted: 08 12 2020
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 18 8 2021
Statut: epublish

Résumé

Identifying endogenous tissue stem cells remains a key challenge in developmental and regenerative biology. To distinguish and molecularly characterise stem cell populations in large heterogeneous tissues, the combination of cytochemical cell markers with ultrastructural morphology is highly beneficial. Here, we realise this through workflows of multi-resolution immuno-correlative light and electron microscopy (iCLEM) methodologies. Taking advantage of the antigenicity preservation of the Tokuyasu technique, we have established robust protocols and workflows and provide a side-by-side comparison of iCLEM used in combination with scanning EM (SEM), scanning TEM (STEM), or transmission EM (TEM). Evaluation of the applications and advantages of each method highlights their practicality for the identification, quantification, and characterization of heterogeneous cell populations in small organisms, organs, or tissues in healthy and diseased states. The iCLEM techniques are broadly applicable and can use either genetically encoded or cytochemical markers on plant, animal and human tissues. We demonstrate how these protocols are particularly suited for investigating neural stem and progenitor cell populations of the vertebrate nervous system.

Identifiants

pubmed: 33441723
doi: 10.1038/s41598-020-79637-9
pii: 10.1038/s41598-020-79637-9
pmc: PMC7806999
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

899

Références

J Struct Biol. 2002 Apr-May;138(1-2):58-62
pubmed: 12160701
Sci Rep. 2016 Sep 26;6:34062
pubmed: 27666401
Methods Cell Biol. 2012;111:325-56
pubmed: 22857936
Histochem Cell Biol. 2008 Aug;130(2):211-7
pubmed: 18575880
Exp Cell Res. 1986 Sep;166(1):209-19
pubmed: 2874992
J Microsc. 2009 Feb;233(2):309-19
pubmed: 19220697
Glia. 2010 May;58(7):870-88
pubmed: 20155821
Cell. 1999 Jun 11;97(6):703-16
pubmed: 10380923
Dev Biol. 2016 Dec 1;420(1):120-135
pubmed: 27693369
Science. 2018 Feb 23;359(6378):
pubmed: 29472455
Methods Cell Biol. 2012;111:175-201
pubmed: 22857929
Methods Cell Biol. 2010;96:619-48
pubmed: 20869541
Eur J Neurosci. 2014 Dec;40(11):3591-607
pubmed: 25231569
Development. 2019 Feb 18;146(4):
pubmed: 30777863
J Comp Neurol. 2016 Oct 15;524(15):2982-92
pubmed: 26991819
J Microsc. 1986 Aug;143(Pt 2):139-49
pubmed: 3531524
Nat Methods. 2015 Jun;12(6):503-13
pubmed: 26020503
Leukemia. 2003 Jun;17(6):1042-8
pubmed: 12764366
Cell. 2012 Jan 20;148(1-2):33-45
pubmed: 22265400
Traffic. 2008 Nov;9(11):1828-38
pubmed: 18817522
Nat Rev Mol Cell Biol. 2003 Sep;Suppl:SS6-10
pubmed: 14587520
J Cell Biol. 2011 Jan 10;192(1):111-9
pubmed: 21200030
Development. 2018 Jun 21;145(12):
pubmed: 29802150
Development. 2016 Apr 1;143(7):1075-86
pubmed: 27048686
Exp Toxicol Pathol. 1996 Feb;48(2-3):175-81
pubmed: 8672872
J Vis Exp. 2017 Nov 10;(129):
pubmed: 29155784
J Neurosci. 1997 Jul 1;17(13):5046-61
pubmed: 9185542
Prog Neurobiol. 2018 Nov;170:99-114
pubmed: 29902500
Methods Cell Biol. 2014;124:275-303
pubmed: 25287846
Sci Rep. 2019 Mar 14;9(1):4420
pubmed: 30872640
Sci Rep. 2018 Aug 2;8(1):11610
pubmed: 30072703
Nat Protoc. 2007;2(10):2480-91
pubmed: 17947990
Stem Cells. 2017 Sep;35(9):2071-2082
pubmed: 28733998
Traffic. 2019 May;20(5):346-356
pubmed: 30895685
Methods Mol Biol. 2014;1117:541-58
pubmed: 24357379
Glia. 2012 Mar;60(3):343-57
pubmed: 22105794
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Development. 2011 Nov;138(22):4831-41
pubmed: 22007133
Methods Cell Biol. 2014;124:241-58
pubmed: 25287844
Biol Open. 2012 Jun 15;1(6):607-14
pubmed: 23213454
Glia. 2010 Aug 15;58(11):1345-63
pubmed: 20607866
Sci Rep. 2019 Mar 1;9(1):3211
pubmed: 30824844
J Microsc. 2015 Dec;260(3):235-7
pubmed: 26769194
Dis Model Mech. 2012 Mar;5(2):200-9
pubmed: 22028327
Brain Res Bull. 2002 Apr;57(6):765-75
pubmed: 12031273
Nat Methods. 2008 Nov;5(11):973-80
pubmed: 18974735
Cell Stem Cell. 2015 May 7;16(5):465-76
pubmed: 25957902
Nature. 2018 May;557(7705):322-328
pubmed: 29769669
J Comp Neurol. 2011 Dec 1;519(17):3549-65
pubmed: 21800305
Development. 2017 Apr 15;144(8):1462-1471
pubmed: 28289134
J Comp Neurol. 2012 Jul 1;520(10):2275-316
pubmed: 22318736
Methods Mol Biol. 2013;950:417-37
pubmed: 23086888
Methods Cell Biol. 2012;111:xvii-xix
pubmed: 22857938

Auteurs

Viola Oorschot (V)

Ramaciotti Centre for Cryo EM, Monash University, Melbourne, VIC, 3800, Australia.
European Molecular Biology Laboratory, Electron Microscopy Core Facility, Heidelberg, Germany.

Benjamin W Lindsey (BW)

Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, 3800, Australia.
Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, R3E 0J9, Canada.

Jan Kaslin (J)

Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, 3800, Australia. jan.kaslin@monash.edu.

Georg Ramm (G)

Ramaciotti Centre for Cryo EM, Monash University, Melbourne, VIC, 3800, Australia. georg.ramm@monash.edu.
Department of Biochemistry, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia. georg.ramm@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH